Fmoc-D-Asp-OH

Fmoc-D-Asp-OH is the Fmoc-protected D-enantiomer of aspartic acid, providing a chiral, side-chain carboxylic acid functionality on the β-carbon while the α-amino group is masked as an Fmoc carbamate. The molecule combines an orthogonally removable N-protecting group (Fmoc) with a free carboxylic acid that can participate in selective coupling, salt formation, or further derivatization. The D configuration at the stereogenic center supports incorporation into stereochemically defined peptide sequences and peptidomimetic scaffolds. The presence of two carboxyl groups enables controlled formation of peptide bonds at the α-position while supporting side-chain activation strategies for downstream functionalization.

1. Fmoc Solid-Phase Peptide Synthesis

Fmoc-D-Asp-OH is applied in Fmoc-based solid-phase peptide synthesis where the Fmoc carbamate enables stepwise N-deprotection and peptide bond formation under standard coupling chemistries. The D-aspartate stereocenter and the side-chain carboxylic acid allow construction of peptides with defined stereochemistry and acidic side-chain topology, which can influence backbone conformation and local electrostatics. The dual carboxyl functionality supports side-chain protection planning, such as orthogonal masking to prevent undesired crosslinking or intramolecular reactions during chain assembly. The resulting aspartate-containing peptide building blocks can be used to generate stereochemically controlled sequences for biochemical research and structure-activity relationship studies.

2. Unnatural Amino Acid Incorporation

Fmoc-D-Asp-OH serves as a chiral amino acid building block for incorporating D-aspartate into peptides and peptidomimetics to probe stereochemical effects on molecular recognition. The Fmoc-protected α-amine supports compatibility with automated peptide synthesis workflows, while the free side-chain carboxyl group can be converted into amides, esters, or activated derivatives depending on the target scaffold. The D configuration can be leveraged to modulate protease stability and alter conformational preferences in sequence design without changing the overall aspartate motif. Downstream derivatives prepared from this amino acid can feed combinatorial libraries and fragment-based molecular design efforts in synthetic organic chemistry and chemical biology.

3. Side-Chain Functionalization Chemistry

Fmoc-D-Asp-OH is utilized for side-chain functionalization strategies that start from the β-carboxylic acid and proceed to chemically defined aspartate derivatives. The molecule's orthogonally removable Fmoc group allows selective manipulation of the side-chain functionality after N-deprotection, enabling formation of amide linkages, ester prodrugs, or carboxylate-based conjugation handles. The stereochemical integrity of the D-aspartate center supports consistent structure-function relationships when generating analogs for binding studies or enzyme interaction assays. Functionalized aspartate intermediates derived from this compound can be used as modular units in peptidomimetic construction, chemical biology probes, and synthetic methodology development.

4. Bioconjugation And Linker Design

Fmoc-D-Asp-OH can be applied in bioconjugation and linker design where an aspartate-derived carboxylate provides a chemically addressable attachment point for coupling to biomolecules. The Fmoc protection supports controlled introduction into peptide-based conjugates, while the side-chain carboxylic acid can be activated for amide bond formation to generate stable conjugation motifs. The D stereochemistry may be exploited to tune resistance to enzymatic cleavage in peptide linkers and to maintain defined spatial orientation in multicomponent constructs. Conjugate-ready aspartate building blocks prepared from Fmoc-D-Asp-OH can support analytical labeling workflows, biomolecule modification, and research intermediate preparation for downstream material or diagnostic chemistry.

5. Pharmaceutical Intermediate Preparation

Fmoc-D-Asp-OH is relevant to pharmaceutical intermediate preparation and process chemistry routes that require stereodefined aspartate units for peptide-like or carboxylate-rich intermediates. The Fmoc carbamate provides a robust N-protection strategy that can be removed cleanly when moving from protected building blocks to reactive amine-bearing intermediates. The side-chain carboxylic acid can be selectively transformed into activated esters or amide-forming derivatives, enabling incorporation into larger synthetic sequences that build drug candidates or bioactive peptidomimetic scaffolds. Manufacturing-oriented workflows can employ this compound as a chiral amino acid intermediate to support controlled stereochemistry, predictable functional group reactivity, and scalable fine chemical synthesis planning.

6. Analytical Standards And Method Development

Fmoc-D-Asp-OH is suitable for analytical research and method development where stereochemically defined aspartate-containing standards support LC-MS, chiral analysis, and peptide mapping workflows. The Fmoc group provides a strong chromophore/ionization handle for monitoring protected amino acid forms and for tracking deprotection and coupling steps in peptide synthesis development. The D configuration and side-chain carboxyl group enable discrimination from L-aspartate analogs and support accurate interpretation of stereochemical outcomes in synthetic and biochemical experiments. Reference materials derived from Fmoc-D-Asp-OH can be used to validate analytical methods, characterize peptide intermediates, and support quality-by-design studies in applied amino acid chemistry.

1. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction

2. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

3. Effect of Short-Term Desiccation, Recovery Time, and CAPA-PVK Neuropeptide on the Immune System of the Burying Beetle Nicrophorus vespilloides

4. Crystal Structure of BamB from Pseudomonas aeruginosa and Functional Evaluation of Its Conserved Structural Features

5. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation